Treatment strategy in post-transplant diabetes (notice n° 152477)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 01050cam a2200205 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250112030518.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | El Azizi, Lamiaa |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Treatment strategy in post-transplant diabetes |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2022.<br/> |
500 ## - GENERAL NOTE | |
General note | 87 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Post-transplant diabetes is defined as the onset of diabetes in a transplant recipient. Its prevalence is discordant, varying from 2 to 53%, and its occurrence is associated with an unfavorable prognosis, including cardiovascular complications, a risk of excess mortality, and graft dysfunction. Screening methods, means of prevention, and therapeutic strategies will differ. |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Melki, Fatima Zahra |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aynaou, Hayat |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Salhi, Houda |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | El Ouahabi, Hanan |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Cahiers Santé Médecine Thérapeutique | 31 | 5-6 | 2022-09-01 | p. 258-264 | 2780-8858 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-cahiers-sante-medecine-therapeutique-2022-5-6-page-258?lang=en">https://shs.cairn.info/journal-cahiers-sante-medecine-therapeutique-2022-5-6-page-258?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux